Plasma nociceptin/orphanin FQ levels are lower in patients with chronic ischemic cardiovascular diseases-A pilot study

Regulatory Peptides

Volumn 169, Issue 1-3, 2011, Pages 1-5

  Krepuska, Miklós ^a   Sótonyi, Péter ^a   Csobay Novák, Csaba ^a   Szeberin, Zoltán ^a   Hartyánszky, István ^a   Zima, Endre ^a   Szilágyi, Nóra ^b   Horkay, Ferenc ^a   Merkely, Béla ^a   Acsády, György ^a   Tekes, Kornélia ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Angina pectoris; Aortic valve stenosis; Coronary stenosis; Nociceptin orphanin FQ; Peripheral artery disease

Indexed keywords

NOCICEPTIN;

ADULT; AGED; AORTA VALVE STENOSIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GANGRENE; HUMAN; INTERMITTENT CLAUDICATION; LIMB PAIN; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STABLE ANGINA PECTORIS; THORAX PAIN;

AGED; ANGINA PECTORIS; DOWN-REGULATION; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OPIOID PEPTIDES; PERIPHERAL ARTERIAL DISEASE; PILOT PROJECTS;

ANGINA;

EID: 79957987158     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.01.007     Document Type: Article

References (46)

1. Acosta C., Davies A. Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons. J Neurosci Res 2008, 86:1077-1086.
2. Anderberg U.M., Liu Z., Berglund L., Nyberg F. Plasma levels on nociceptin in female fibromyalgia syndrome patients. Z Rheumatol 1998, 57(Suppl 2):77-80.
3. Armstead W.M. Relationship between nociceptin/orphanin FQ and cerebral hemodynamics after hypoxia-ischemia in piglets. Am J Physiol Heart Circ Physiol 2000, 278:H477-H483.
4. Brooks H., Elton C.D., Smart D., Rowbotham D.J., McKnight A.T., Lambert D.G. Identification of nociceptin in human cerebrospinal fluid: comparison of levels in pain and non-pain states. Pain 1998, 78:71-73.
5. Calo G., Guerrini R., Rizzi A., Salvadori S., Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol 2000, 129:1261-1283.
6. Campeau L. Letter: grading of angina pectoris. Circulation 1976, 54:522-523.
7. Champion H.C., Kadowitz P.J. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat. Life Sci 1997, 60:PL241-PL245.
8. Czapla M.A., Champion H.C., Kadowitz P.J. Decreases in systemic arterial and hindquarters perfusion pressure in response to nociceptin are not inhibited by naloxone in the rat. Peptides 1997, 18:1197-1200.
9. Czapla M.A., Champion H.C., Kadowitz P.J. Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat. Peptides 1997, 18:793-795.
10. Doggrell S.A. Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target?. Curr Opin Investig Drugs 2007, 8:742-749.
11. Ertsey C., Hantos M., Bozsik G., Tekes K. Circulating nociceptin levels during the cluster headache period. Cephalalgia 2004, 24:280-283.
12. Ertsey C., Hantos M., Bozsik G., Tekes K. Plasma nociceptin levels are reduced in migraine without aura. Cephalalgia 2005, 25:261-266.
13. Fiset M.E., Gilbert C., Poubelle P.E., Pouliot M. Human neutrophils as a source of nociceptin: a novel link between pain and inflammation. Biochemistry 2003, 42:10498-10505.
14. Fontana F., Bernardi P., Pizzi C., Spampinato S., Bedini A., Pich E.M. Plasma nociceptin/orphanin FQ levels rise after spontaneous episodes of angina, but not during induced myocardial ischemia. Peptides 2009, 30:1705-1709.
15. Fraker T.D., Fihn S.D., Gibbons R.J., Abrams J., Chatterjee K., Daley J., et al. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation 2007, 116:2762-2772.
16. Giuliani S., Maggi C.A. Prejunctional modulation by nociceptin of nerve-mediated inotropic responses in guinea-pig left atrium. Eur J Pharmacol 1997, 332:231-236.
17. Giuliani S., Tramontana M., Lecci A., Maggi C.A. Effect of nociceptin on heart rate and blood pressure in anaesthetized rats. Eur J Pharmacol 1997, 333:177-179.
18. Gumusel B., Hao Q., Hyman A., Chang J.K., Kapusta D.R., Lippton H. Nociceptin: an endogenous agonist for central opioid like1 (ORL1) receptors possesses systemic vasorelaxant properties. Life Sci 1997, 60:PL141-PL145.
19. Guo Z., Yao T.P., Wang J.P., Ding J.Y. Acute myocardial ischemia up-regulates nociceptin/orphanin FQ in dorsal root ganglion and spinal cord of rats. Neurosci Lett 2008, 433:274-278.
20. Hantos M.B., Szalay F., Lakatos P.L., Hegedus D., Firneisz G., Reiczigel J., et al. Elevated plasma nociceptin level in patients with Wilson disease. Brain Res Bull 2002, 58:311-313.
21. Horvath A., Folhoffer A., Lakatos P.L., Halosz J., Illyes G., Schaff Z., et al. Rising plasma nociceptin level during development of HCC: a case report. World J Gastroenterol 2004, 10:152-154.
22. http://www.americanheart.org/presenter.jhtml?identifier=4478.
23. http://www.heartstats.org/topic.asp?id=17.
24. Jhamandas K.H., Sutak M., Henderson G. Antinociceptive and morphine modulatory actions of spinal orphanin FQ. Can J Physiol Pharmacol 1998, 76:314-324.
25. Kapusta D.R., Burmeister M.A., Calo G., Guerrini R., Gottlieb H.B., Kenigs V.A. Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function. J Pharmacol Exp Ther 2005, 314:643-651.
26. Kapusta D.R., Dayan L.A., Kenigs V.A. Nociceptin/orphanin FQ modulates the cardiovascular, but not renal, responses to stress in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2002, 29:254-259.
27. Kapusta D.R., Sezen S.F., Chang J.K., Lippton H., Kenigs V.A. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci 1997, 60:PL15-PL21.
28. Ko M.H., Kim Y.H., Woo R.S., Kim K.W. Quantitative analysis of nociceptin in blood of patients with acute and chronic pain. NeuroReport 2002, 13:1631-1633.
29. Lambert D.G. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov 2008, 7:694-710.
30. Leggett J.D., Dawe K.L., Jessop D.S., Fulford A.J. Endogenous nociceptin/orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation. J Neuroendocrinol 2009, 21:888-897.
31. Lutfy K., Maidment N.T. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test. Br J Pharmacol 2000, 131:1684-1688.
32. Malinowska B., Godlewski G., Schlicker E. Function of nociceptin and opioid OP4 receptors in the regulation of the cardiovascular system. J Physiol Pharmacol 2002, 53:301-324.
33. Mandyam C.D., Thakker D.R., Standifer K.M. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity. J Pharmacol Exp Ther 2003, 306:965-972.
34. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995, 377:532-535.
35. Mogil J.S., Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 2001, 53:381-415.
36. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 270:792-794.
37. Szalay F., Hantos M.B., Horvath A., Lakatos P.L., Folhoffer A., Dunkel K., et al. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma. World J Gastroenterol 2004, 10:42-45.
38. Tekes K., Hantos M., Bator G., Gyenge M., Laufer R., Folyovich A. Endogenous nociceptin level in ischemic stroke: connection to serotonin system. Neuropsychopharmacol Hung 2006, 8:53-59.
39. Tekes K., Gyenge M., Bizderi B., Kecskeméti V. Diabetes and endogenous orphanin FQ/nociceptin levels in rat CSF and plasma. Int J Diab Metabol 2005, 147-153.
40. Vahanian A., Baumgartner H., Bax J., Butchart E., Dion R., Filippatos G., et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007, 28:230-268.
41. Wainford R.D., Kapusta D.R. Chronic high-NaCl intake prolongs the cardiorenal responses to central N/OFQ and produces regional changes in the endogenous brain NOP receptor system. Am J Physiol Regul Integr Comp Physiol 2009, 296:R280-R288.
42. Waits P.S., Purcell W.M., Fulford A.J., McLeod J.D. Nociceptin/orphanin FQ modulates human T cell function in vitro. J Neuroimmunol 2004, 149:110-120.
43. Williams J.P., Thompson J.P., McDonald J., Barnes T.A., Cote T., Rowbotham D.J., et al. Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not mu, delta, or kappa opioid receptors. Anesth Analg 2007, 105:998-1005. [table of contents].
44. Williams J.P., Thompson J.P., Rowbotham D.J., Lambert D.G. Human peripheral blood mononuclear cells produce pre-pro-nociceptin/orphanin FQ mRNA. Anesth Analg 2008, 106:865-866. [table of contents].
45. Williams J.P., Thompson J.P., Young S.P., Gold S.J., McDonald J., Rowbotham D.J., et al. Nociceptin and urotensin-II concentrations in critically ill patients with sepsis. Br J Anaesth 2008, 100:810-814.
46. Xie G.X., Ito E., Maruyama K., Suzuki Y., Sugano S., Sharma M., et al. The promoter region of human prepro-nociceptin gene and its regulation by cyclic AMP and steroid hormones. Gene 1999, 238:427-436.